1 |
Reibel J, Gale N, Hille J, et al. Oral potentially malignant disorders and oral epithelial dysplasia[M]//El-Naggar AK, Chan JK, Grandis JR, et al. WHO classification of head and neck tumours. 4th ed. Lyon: IARC, 2017: 112-115.
|
2 |
Cawson RA. Leukoplakia and oral cancer[J]. Proc Royal Soc Med, 1969, 62(6): 610-615.
|
3 |
姜倩. 人口腔白斑及鳞状细胞癌中NF-κB/p65、cyclin D1及CD105表达的研究[D]. 郑州: 郑州大学, 2007: 1-27.
|
|
Jiang Q. Study on the expression of NF-ΚB/p65, cyclin D1 and CD105 in human oral leukoplakia and squamous cell carcinoma[D]. Zhengzhou: Zhengzhou University, 2007: 1-27.
|
4 |
蓝勇. 中国饮食辛辣口味的地理分布及其成因研究[J].人文地理, 2001, 16(5): 84-88.
|
|
Lan Y. Study on the geographical distribution and causes of Chinese food spicy flavors[J]. Human Geograp, 2001,16(5): 84-88.
|
5 |
Yan S, Li B, Bai ZZ, et al. Clinical epidemiology of gastric cancer in Hehuang valley of China: a 10-year epidemiological study of gastric cancer[J]. World J Gastroenterol, 2014, 20(30): 10486-10494.
|
6 |
Zheng J, Zhou Y, Li Y, et al. Spices for prevention and treatment of cancers[J]. Nutrients, 2016, 8(8): E495.
|
7 |
Ibiebele TI, Taylor AR, Whiteman DC, et al. Eating ha-bits and risk of esophageal cancers: a population-based case-control study[J]. Cancer Causes Control, 2010, 21(9): 1475-1484.
|
8 |
Winn DM. Diet and nutrition in the etiology of oral cancer[J]. Am J Clin Nutr, 1995, 61(2): 437S-445S.
|
9 |
Urruticoechea A, Smith IE, Dowsett M. Proliferation marker Ki-67 in early breast cancer[J]. J Clin Oncol, 2005, 23(28): 7212-7220.
|
10 |
Menon SS, Guruvayoorappan C, Sakthivel KM, et al. Ki-67 protein as a tumour proliferation marker[J]. Clin Chim Acta, 2019, 491: 39-45.
|
11 |
Nasser W, Flechtenmacher C, Holzinger D, et al. Aberrant expression of p53, p16INK4a and Ki-67 as basic biomarker for malignant progression of oral leukoplakias[J]. J Oral Pathol Med, 2011, 40(8): 629-635.
|
12 |
Stacey DW. Cyclin D1 serves as a cell cycle regulatory switch in actively proliferating cells[J]. Curr Opin Cell Biol, 2003, 15(2): 158-163.
|
13 |
Arnold A, Papanikolaou A. Cyclin D1 in breast cancer pathogenesis[J]. J Clin Oncol, 2005, 23(18): 4215-4224.
|
14 |
Joerger AC, Fersht AR. The p53 pathway: origins, inactivation in cancer, and emerging therapeutic approaches[J]. Annu Rev Biochem, 2016, 85: 375-404.
|
15 |
Bykov VJ, Eriksson SE, Bianchi J, et al. Targeting mutant p53 for efficient cancer therapy[J]. Nat Rev Cancer, 2018, 18(2): 89-102.
|
16 |
李群, 关为群, 张杨安, 等. 骨膜蛋白和P53在口腔白斑及鳞状细胞癌组织中的表达及意义[J]. 国际口腔医学杂志, 2019, 46(1): 5-11.
|
|
Li Q, Guan WQ, Zhang YA, et al. Expression and signi-ficance of periosteal protein and P53 in oral leukoplakia and squamous cell carcinoma[J]. Int J Stomatol, 2019, 46(1): 5-11.
|
17 |
Witkiewicz AK, Knudsen KE, Dicker AP, et al. The meaning of p16(ink4a) expression in tumors: functional significance, clinical associations and future developments[J]. Cell Cycle, 2011, 10(15): 2497-2503.
|
18 |
Zhao R, Choi BY, Lee MH, et al. Implications of genetic and epigenetic alterations of CDKN2A p16(INK4a) in cancer[J]. EBioMedicine, 2016, 8: 30-39.
|
19 |
March-Villalba JA, Ramos-Soler D, Soriano-Sarrió P, et al. Immunohistochemical expression of Ki-67, Cyclin D1, p16INK4a, and Survivin as a predictive tool for recurrence and progression-free survival in papillary urothelial bladder cancer pTa/pT1 G2 (WHO 1973)[J]. Urol Oncol, 2019, 37(2): 158-165.
|
20 |
程晓华, 陈学升. P16在口腔白斑和鳞癌组织中的表达及其意义[J]. 广东牙病防治, 2010, 18(10): 521-523.
|
|
Cheng XH, Chen XS. Expression of P16 in oral leukoplakia and oral squamous cell carcinoma[J]. J Dent Prev Treat, 2010, 18(10): 521-523.
|
21 |
Ryu HJ, Kim EK, Heo SJ, et al. Architectural patterns of p16 immunohistochemical expression associated with cancer immunity and prognosis of head and neck squamous cell carcinoma[J]. APMIS, 2017, 125(11): 974-984.
|
22 |
Padhi SS, Roy S, Kar M, et al. Role of CDKN2A/p16 expression in the prognostication of oral squamous cell carcinoma[J]. Oral Oncol, 2017, 73: 27-35.
|
23 |
Phukan RK, Chetia CK, Ali MS, et al. Role of dietary habits in the development of esophageal cancer in Assam, the north-eastern region of India[J]. Nutr Cancer, 2001, 39(2): 204-209.
|
24 |
Tawani A, Amanullah A, Mishra A, et al. Evidences for Piperine inhibiting cancer by targeting human G-quadruplex DNA sequences[J]. Sci Rep, 2016, 6: 39239.
|
25 |
Vendrely V, Amintas S, Noel C, et al. Combination treatment of resveratrol and capsaicin radiosensitizes pancreatic tumor cells by unbalancing DNA repair response to radiotherapy towards cell death[J]. Cancer Lett, 2019, 451: 1-10.
|